| Descriptor English: | Dopamine Antagonists | ||||||
| Descriptor Spanish: |
Antagonistas de Dopamina
| ||||||
| Descriptor Portuguese: | Antagonistas de Dopamina | ||||||
| Descriptor French: | Antagonistes de la dopamine | ||||||
| Entry term(s): |
Antagonist, Dopamine Antagonist, Dopamine Receptor Antagonist, Dopaminergic Antagonists, Dopamine Antagonists, Dopamine Receptor Antagonists, Dopaminergic Blocker, Dopamine Blockers, Dopamine Dopamine Antagonist Dopamine Blocker Dopamine Blockers Dopamine Receptor Antagonist Dopamine Receptor Antagonists Dopaminergic Antagonist Dopaminergic Antagonists Receptor Antagonist, Dopamine Receptor Antagonists, Dopamine |
||||||
| Tree number(s): |
D27.505.519.625.150.175 D27.505.696.577.150.175 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D018492 | ||||||
| Scope note: | Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Previous Indexing: |
Dopamine/antagonists & inhibitors (1966-1994) |
||||||
| Public MeSH Note: | 95 |
||||||
| History Note: | 95 |
||||||
| Entry Version: | DOPAMINE ANTAG |
||||||
| DeCS ID: | 32275 | ||||||
| Unique ID: | D018492 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1995/01/01 | ||||||
| Date of Entry: | 1994/06/01 | ||||||
| Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses -
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Dopamine Antagonists
- Preferred
| Concept UI |
M0027734 |
| Scope note | Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. |
| Preferred term | Dopamine Antagonists |
| Entry term(s) |
Antagonist, Dopamine Antagonist, Dopamine Receptor Antagonist, Dopaminergic Antagonists, Dopamine Antagonists, Dopamine Receptor Antagonists, Dopaminergic Blocker, Dopamine Blockers, Dopamine Dopamine Antagonist Dopamine Blocker Dopamine Blockers Dopamine Receptor Antagonist Dopamine Receptor Antagonists Dopaminergic Antagonist Dopaminergic Antagonists Receptor Antagonist, Dopamine Receptor Antagonists, Dopamine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
